Hong Kong, meanwhile, reports a respirator shortage.
The CDC issues a watch but does not call for travel limits.
The outbreak raises questions about not only the pathogen, but how patients were exposed.
Local sources say the market linked to the cases sold some live animals and animal organs, raising concerns about zoonotic virus spread.
Health officials in China are investigating the cause of a pneumonia outbreak in the city of Wuhan in Hubei province that has sickened 27 people and seems to be linked to a seafood market.
The US Food and Drug Administration (FDA) today approved a new test to diagnose methicillin-resistant Staphylococcus aureus (MRSA), which will allow health workers to screen patients for MRSA colonization more quickly—in as little as 5 hours compared with 24 to 48 hours for traditional culture-based tests.
Rapid, biomarker-guided tests did not help cut antibiotic use in ICU patients.
Takeda's dengue vaccine candidate (TAK-003) is safe and effective against dengue virus, according to part 1 of phase 3 clinical trial results published yesterday in the New England Journal of Medicine.
Nonprofit drug developer TB Alliance announced today that it will partner with an Indian company to manufacture and commercialize pretomanid for treating extensively drug-resistant tuberculosis (XDR-TB).
An analysis of almost 160,000 pneumonia patients in 170 US hospitals indicates that urinary antigen testing (UAT), a practice recommended by national guidelines to allow for antibiotic de-escalation in patients with community-acquired pneumonia (CAP), is not widely performed, researchers reported today in Clinical Infectious Diseases.